These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31343304)

  • 21. The Swedish open-label diflunisal trial (DFNS01) on hereditary transthyretin amyloidosis and the impact of amyloid fibril composition.
    Wixner J; Westermark P; Ihse E; Pilebro B; Lundgren HE; Anan I
    Amyloid; 2019; 26(sup1):39-40. PubMed ID: 31343354
    [No Abstract]   [Full Text] [Related]  

  • 22. Vitreous opacities in a case of familial amyloidotic polyneuropathy associated with a transthyretin Lys 54.
    Imasawa M; Toda Y; Sakurada Y; Imai M; Iijima H
    Acta Ophthalmol Scand; 2004 Oct; 82(5):635-7. PubMed ID: 15453875
    [No Abstract]   [Full Text] [Related]  

  • 23. Failure of Tafamidis to Halt Progression of Ala36Pro TTR Oculomeningovascular Amyloidosis.
    Salvi F; Volpe R; Pastorelli F; Bianchi A; Vella A; Rapezzi C; Mascalchi M
    J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):e212-e214. PubMed ID: 29779881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chinese familial transthyretin amyloidosis with vitreous involvement is associated with the transthyretin mutation Gly83Arg: a case report and literature review.
    Yin J; Xia X; Shi Y; Lu Y; Zhao C; Huang Z; Tian N
    Amyloid; 2014 Jun; 21(2):140-2. PubMed ID: 24601824
    [No Abstract]   [Full Text] [Related]  

  • 25. Enthalpy-Driven Stabilization of Transthyretin by AG10 Mimics a Naturally Occurring Genetic Variant That Protects from Transthyretin Amyloidosis.
    Miller M; Pal A; Albusairi W; Joo H; Pappas B; Haque Tuhin MT; Liang D; Jampala R; Liu F; Khan J; Faaij M; Park M; Chan W; Graef I; Zamboni R; Kumar N; Fox J; Sinha U; Alhamadsheh M
    J Med Chem; 2018 Sep; 61(17):7862-7876. PubMed ID: 30133284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oculoleptomeningeal Amyloidosis Secondary to the Rare Transthyretin c.381T>G (p.Ile127Met) Mutation.
    Mathieu F; Morgan E; So J; Munoz DG; Mason W; Kongkham P
    World Neurosurg; 2018 Mar; 111():190-193. PubMed ID: 29277593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two cases of late onset familial amyloid polyneuropathy with a Glu61Lys transthyretin variant.
    Nakano Y; Tadokoro K; Ohta Y; Sato K; Takemoto M; Hishikawa N; Yamashita T; Yamashita T; Ando Y; Abe K
    J Neurol Sci; 2018 Jul; 390():22-25. PubMed ID: 29801893
    [No Abstract]   [Full Text] [Related]  

  • 28. Ocular Manifestations of Familial Transthyretin Amyloidosis.
    Reynolds MM; Veverka KK; Gertz MA; Dispenzieri A; Zeldenrust SR; Leung N; Pulido JS
    Am J Ophthalmol; 2017 Nov; 183():156-162. PubMed ID: 28911993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural stabilization of transthyretin by a new compound, 6-benzoyl-2-hydroxy-1H-benzo[de]isoquinoline-1,3(2H)-dione.
    Yokoyama T; Takaki S; Chosa K; Sato T; Suico MA; Teranishi Y; Shuto T; Mizuguchi M; Kai H
    J Pharmacol Sci; 2015 Dec; 129(4):240-3. PubMed ID: 26639444
    [TBL] [Abstract][Full Text] [Related]  

  • 30. When to suspect transthyretin amyloidosis in cases of isolated vitreous opacities?
    Poignet B; Cauquil C; Barreau E; Bodaghi B; Terrada C; Adams D; Francou B; Labetoulle M; Rousseau A
    Amyloid; 2020 Dec; 27(4):277-278. PubMed ID: 32500742
    [No Abstract]   [Full Text] [Related]  

  • 31. [Transthyretin Arg-83 mutation in vitreous amyloidosis].
    Chen L; Lü L; Zhang P; Li Y; Lin J
    Yan Ke Xue Bao; 2008 Mar; 24(1):65-7. PubMed ID: 18709962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modeling familial amyloidotic polyneuropathy (Transthyretin V30M) in Drosophila melanogaster.
    Berg I; Thor S; Hammarström P
    Neurodegener Dis; 2009; 6(3):127-38. PubMed ID: 19372706
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.
    Sekijima Y
    J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):1036-43. PubMed ID: 25604431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of diflunisal on clusterin levels in ATTRwt amyloidosis.
    Torres-Arancivia C; Connors LH
    Amyloid; 2019; 26(sup1):49-50. PubMed ID: 31343317
    [No Abstract]   [Full Text] [Related]  

  • 35. Late-onset Transthyretin (TTR)-familial Amyloid Polyneuropathy (FAP) with a Long Disease Duration from Non-endemic Areas in Japan.
    Miyake Z; Nakamagoe K; Ezawa N; Yoshinaga T; Hashimoto R; Sato T; Sekijima Y; Tamaoka A
    Intern Med; 2019 Mar; 58(5):713-718. PubMed ID: 30333406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hereditary transthyretin-related amyloidosis.
    Finsterer J; Iglseder S; Wanschitz J; Topakian R; Löscher WN; Grisold W
    Acta Neurol Scand; 2019 Feb; 139(2):92-105. PubMed ID: 30295933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clusterin regulates transthyretin amyloidosis.
    Lee KW; Lee DH; Son H; Kim YS; Park JY; Roh GS; Kim HJ; Kang SS; Cho GJ; Choi WS
    Biochem Biophys Res Commun; 2009 Oct; 388(2):256-60. PubMed ID: 19664600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A mouse model of a novel missense mutation (Gly83Arg) in a Chinese kindred manifesting vitreous amyloidosis only.
    Ran LX; Zheng ZY; Xie B; Nie XM; Chen XW; Su G; Cai SJ
    Exp Eye Res; 2018 Apr; 169():13-19. PubMed ID: 29360446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TTR (Transthyretin) Stabilizers Are Associated With Improved Survival in Patients With TTR Cardiac Amyloidosis.
    Rosenblum H; Castano A; Alvarez J; Goldsmith J; Helmke S; Maurer MS
    Circ Heart Fail; 2018 Apr; 11(4):e004769. PubMed ID: 29615436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biochemical characterization of vitreous and cardiac amyloid in Ile84Ser transthyretin amyloidosis.
    Liepnieks JJ; Wilson DL; Benson MD
    Amyloid; 2006 Sep; 13(3):170-7. PubMed ID: 17062384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.